# Association Between Genetic Variant Scores and Warfarin Effect

> **NCT03894878** · — · COMPLETED · sponsor: **Cipherome, Inc.** · enrollment: 200 (actual)

## Conditions studied

- Atrial Fibrillation
- Deep Vein Thrombosis
- Intracardiac Thrombus
- Pulmonary Embolism
- Venous Thromboembolic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03894878
- **Lead sponsor:** Cipherome, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-11
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03894878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03894878, "Association Between Genetic Variant Scores and Warfarin Effect". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03894878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*